Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Yinuo Pharmaceutical is a specialized chemical and pharmaceutical company based in Wuhan, China, focusing on the development and manufacture of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Established in 2005, the company operates out of the East Lake High-tech Development Zone and has built a reputation for expertise in complex small molecule synthesis. Their core product offerings support the production of significant antiviral medications, including treatments for Hepatitis B and HIV, as well as various cardiovascular drugs. Wuhan Yinuo provides comprehensive CDMO services, ranging from laboratory-scale R&D to commercial-scale production, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 武汉亿诺药业.